Marketable Securities, Current in USD of Unity Biotechnology, Inc. from Q4 2017 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Unity Biotechnology, Inc. quarterly Marketable Securities, Current history and change rate from Q4 2017 to Q1 2025.
  • Unity Biotechnology, Inc. Marketable Securities, Current for the quarter ending March 31, 2025 was $8.93M, a 69.1% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

Unity Biotechnology, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $8.93M -$20M -69.1% Mar 31, 2025 10-Q 2025-04-22
Q4 2024 $15.7M -$7.75M -33.1% Dec 31, 2024 10-Q 2025-04-22
Q3 2024 $20.1M -$17.9M -47.1% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $26.4M -$23.6M -47.2% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $28.9M -$31.5M -52.2% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $23.4M -$58.7M -71.5% Dec 31, 2023 10-K 2025-03-07
Q3 2023 $38.1M -$38.3M -50.2% Sep 30, 2023 10-K 2024-04-15
Q2 2023 $50M +$4.91M +10.9% Jun 30, 2023 10-K 2024-04-15
Q1 2023 $60.4M -$2.3M -3.66% Mar 31, 2023 10-K 2024-04-15
Q4 2022 $82.1M +$26.9M +48.7% Dec 31, 2022 10-K 2024-04-15
Q3 2022 $76.4M +$17.4M +29.5% Sep 30, 2022 10-K 2024-04-15
Q2 2022 $45.1M -$25.4M -36% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $62.7M -$10.9M -14.8% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $55.2M -$24.7M -30.9% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $59M -$24.7M -29.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $70.4M -$1.73M -2.4% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $73.6M -$10.6M -12.5% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $79.9M -$4.62M -5.46% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $83.6M +$7.43M +9.75% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $72.2M -$32.7M -31.2% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $84.2M -$31.8M -27.4% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $84.5M -$71.2M -45.7% Dec 31, 2019 10-K 2021-03-23
Q3 2019 $76.2M -$72.7M -48.8% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $105M -$46.9M -30.9% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $116M +$44.7M +62.7% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $156M +$76.5M +96.6% Dec 31, 2018 10-K 2020-03-11
Q3 2018 $149M Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $152M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $71.3M Mar 31, 2018 10-Q 2018-06-07
Q4 2017 $79.2M Dec 31, 2017 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.